Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib alone for advanced hepatocellular carcinoma: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib alone for advanced hepatocellular carcinoma: A systematic review and meta‐analysis

Published:2023-01-16 Issue:4 Volume:38 Page:486-495
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J of Gastro and Hepatol

Author:

Long Yin¹,Song Xingdong¹,Guan Yan²,Lan Ran¹,Huang Ziqi¹,Li Senlin¹³,Zhang Lei¹^ORCID

Affiliation:

1. Department of Hepatology, Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China

2. Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital Guangdong Academy of Medical Sciences Guangzhou China

3. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong‐Hong Kong Joint Laboratory for RNA Medicine, Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China

Funder

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.16088

Reference47 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma

3. Sorafenib in Advanced Hepatocellular Carcinoma